The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancerMaria Letizia Cataldo, Bianca Maria Veneziani, Daniela Esposito et al.|Frontiers in Oncology|2023Cited by 18
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumorsDaniela Esposito, Roberto Bianco|Journal of Experimental & Clinical Cancer Research|2025Cited by 0